Anti-PDE5A/PDE5 antibody
4
(1 Review)
|
(15 Publications)
Rabbit Polyclonal PDE5A/PDE5 antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 15 publications. Immunogen corresponding to Synthetic Peptide within Human PDE5A.
View Alternative Names
PDE5, PDE5A, cGMP-binding cGMP-specific phosphodiesterase, CGB-PDE
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PDE5A/PDE5 antibody (AB14672)
ICC/IF image of ab14672 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab14672, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PDE5A/PDE5 antibody (AB14672)
ab14672 (4μg/ml) staining PDE5A/PDE5 in human oesophagus using an automated system (DAKO Autostainer Plus). Using this protocol there is staining of the cytoplasm and nuclei in stratified squamous epithelium cells.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDE5A regulates intracellular levels of cGMP an important secondary messenger in various signaling pathways. It is not part of a large protein complex but directly influences the contractility of smooth muscle tissues. By controlling cGMP levels PDE5A modulates vascular tone and influences processes such as vasodilation. This regulation is essential for maintaining a balance in the contractile state of muscles impacting blood flow and other vital functions.
Pathways
PDE5A contributes significantly to the nitric oxide (NO)-cGMP signaling pathway which is important for vascular relaxation. In this pathway nitric oxide stimulates guanylate cyclase to produce cGMP which then activates specific kinases and ion channels. Related proteins such as guanylate cyclase and cGMP-dependent protein kinases work alongside PDE5A to mediate smooth muscle relaxation and vasodilation particularly in penile erectile tissue.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Genesis (New York, N.Y. : 2000) 62:e23603 PubMed38738564
2024
Applications
Unspecified application
Species
Unspecified reactive species
Anti-cancer drugs 35:450-458 PubMed38452059
2024
Applications
Unspecified application
Species
Unspecified reactive species
Respiratory research 23:87 PubMed35395852
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:5552530 PubMed34221234
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 12: PubMed33322158
2020
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicine & pharmacotherapy = Biomedecine & phar 118:109216 PubMed31319371
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of the American Heart Association 8:e010961 PubMed31039672
2019
Applications
Unspecified application
Species
Unspecified reactive species
The Prostate 79:909-919 PubMed30958912
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:4628 PubMed30874604
2019
Applications
Unspecified application
Species
Unspecified reactive species
PPAR research 2018:6970407 PubMed29686697
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com